Navigation Links
IRadimed Announces 510K Clearance of the New Non-Magnetic MRidium(TM) MRI IV Pump with Integrated Masimo SET(R) SpO2 Monitoring
Date:8/21/2009

WINTER PARK, Fla., Aug. 17 /PRNewswire/ -- The United States Food and Drug Administration has granted IRadimed Corporation clearance of its new MRidium 3860+ MRI Infusion System with integrated Masimo SET(R) SpO2 Monitoring. Transport to the MRI for Sedation, Critical Care, and Cardiac Patients to date has required multiple pieces of equipment, with hospital infusion pumps and SpO2 being typically not designed to be integrated and functional in the MRI. Clinicians no longer have to remember each time when they get to the door of the MRI to remove their standard hospital SpO2 equipment so that it does not become a dangerous projectile, or risk a patient burn, in the MR environment. IRadimed has innovatively combined two critically needed technologies for the MRI to increase productivity, patient safety, and ease of transport to, from, and within the MRI.

The Innovative MRidium(TM) 3860+ MRI Infusion System is the first Non-Magnetic IV Pump designed specifically for use in the MRI Environment with Integrated Masimo SET(R) technology. "We chose the Masimo SET(R) technology because it has such an excellent reputation in the marketplace. Masimo's systems are viewed by most as one of the best monitoring technologies in the world," said Todd Weber, VP Sales and Marketing. Safety in the MR is the primary concern when it comes to meeting needs for required patient care. These risks are all well-known, as essential IV and monitoring equipment can: fly into the bore, cause artifacts on the images, become unreliable during crucial deliveries of medications and monitoring, or shut down completely when needed the most. Use of improper pulse oximeters has caused severe burns to patients due to the high RF fields involved within MR scanners. "It is critical to have products which have been designed with the utmost care and thorough insight of this harsh and potentially dangerous environment," said Roger Susi, founder of IRadimed Corporation.

In hospitals all around the globe, the patient population going to the MRI is growing every day. Today, more and more hospitals are eliminating the long IV lines under their MR Scanner Room doors. Recent studies indicate the addition of 15 to 30 feet of IV Extension Sets significantly reduces the alarm times of syringe and IV pumps, making delivery of critical medications risky at best. Patients are coming to MRI with more IV lines and new types of cases, such as stressing the heart, inter-operative procedures, brain lab suites, cancer patients, and sedations, with many of these patients needing accurate delivery at lower rates and volumes. The MRidium(TM) System has been designed to meet these changing needs by reducing the risk; there is no need for long IV lines or Syringe pumps placed outside the Magnet Room. No need to remember to remove the standard hospital SpO2 Monitor, because the MRidium(TM) Pump has the ability to maneuver right next to the bore of the MRI and deliver medications safely and efficiently. All while being monitored through its wireless remote control, which operates inside the MRI control room.

The MRidium(TM) Pump has the ability to work at the 10,000 Gauss magnetic field environment of 1.5 and 3.0 Tesla MR Scanners, and the system includes the remote control ability for adjusting critical medication deliveries and alarm monitoring from outside the MR Scanner room. The safe placement of the pump is of the utmost importance, because these safety-critical Gauss line limits are invisible and different for every magnet design and strength, which makes it difficult to know where the safe limits are in relation to the MR Scanner. The 10,000 Gauss Line is virtually inside the bore of the MR Scanner in many cases, which allows the use of the MRidium(TM) Pump in close proximity to the MR scanner.

The MRidium(TM) System's remote ability allows clinicians to monitor the infusion progress and make changes to the pump from outside the MR scanner room without having to stop the scan; this provides the ability to adjust or bolus critical medications, such as Propofol, which is commonly used for MR Anesthesia, without interrupting, or unnecessarily delaying, the MR scan.

The New MRidium(TM) 3860+ System has a number of key new features which make this MR IV Pump simple and safe to deliver even the smallest of infusions. With rate ranges from 0.1 ml to 1400 ml per hour, the MRidium(TM) System is designed to meet all of your infusion needs. The new 10-digit keypad makes programming a snap, with quick changes at the press of a few buttons. This Smart Infusion System also has an integrated programmable drug library designed for the MRI - making it an indispensable tool for delivery of critical medications such as Dobutamine, Adenosine, Propofol, and Dexmedetomidine. The system also offers a modular second channel which allows for delivery of two medications simultaneously during patient scans. A range of available infusion sets provides the necessary clinical flexibility needed for MRI Infusion. The MRidium(TM) 1055 Bypass Infusion set allows clinicians to quickly change over IV sets from the hospital-based infusion system without having to disconnect the lines from the patient. The MRidium(TM) 1057 Vented Syringe Adapter Set allows for accurate delivery from a syringe using a low priming volume of only 4 milliliters per set.

The MRidium(TM) 3860+ MRI IV Pump with Integrated Masimo SET(R) SpO2 Technology is marketed globally through one of their many distributors. To request a demonstration, please contact sales@iradimed.com or call: 1-407-677-8022 and ask for the sales department.

About IRadimed Corporation

IRadimed Corporation has vast experience in MRI safe products and Infusion Therapy. Our founder is the pioneering developer of the world's first and best-selling MRI-compatible monitoring system. Our staff has a combined 60+ years developing MRI-safe products. The MRidium(TM) Infusion System has full benefit of the experience and attention to details so important to the development of quality equipment which can be safely used in the MRI setting.

http://www.iradimed.com

MRidium(TM) is a Trademark of IRadimed Corporation

Masimo(R) and Masimo SET(R) are registered trademarks of Masimo Corporation.

    Contact:

    Todd Weber
    Vice President Sales and Marketing
    IRadimed Corporation
    407-677-8022 Ext. 112
    tweber@iradimed.com

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE IRadimed Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nihon LocalSoft Designs New Japanese Software for IRadimed Corporations Award-Winning MRidium MRI Infusion System
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... The California State University Institute for Palliative Care ... or interested in palliative care education and research. The Symposium, “Innovate. Investigate. Educate: ... San Diego on Sept. 28 and 29, 2017, on the campus of California State ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals ... What You See” body image mannequin art competition. Selected from 15 submissions from around ... winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las ...
(Date:2/24/2017)... ... 2017 , ... The Radiology Business Management Association will select the ... annual Building Better Radiology Marketing Programs conference, held this year from March ... Nine awards are given out in five categories. They are:, , ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... Senior International Elite division on February 12th. Ms. Esparza qualified into this ... elite qualifier competition held in Las Vegas, Nevada. Frida is one of approximately ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the ... The Jensie Gran Fondo of Marin. For the second year in a row, ... mineral-based sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Oesophageal ... their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis and Strategies - ... Cancer market. The research answers the following questions: ... Oesophageal Cancer and their clinical attributes? How are they positioned in ...
(Date:2/23/2017)... 23, 2017 Regulus Therapeutics Inc . ... development of innovative medicines targeting microRNAs, today announced it ... results on Thursday, March 2, 2017 after the market ... and webcast on March 2, 2017 at 5:00 p.m. ... 2016 financial results and provide a general business update.  ...
Breaking Medicine Technology: